3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Squamous Cell Carcinoma of Head and Neck
3
Head and Neck Neoplasms
2
Carcinoma, Squamous Cell
2
Carcinoma, Non-Small-Cell Lung
2
Tongue Neoplasms
1
Salivary Gland Neoplasms
1
Recurrence
1
Neoplasms
1
Nasopharyngeal Carcinoma
1
Lung Neoplasms
1
Klatskin Tumor
1
Cholangiocarcinoma
1
Carcinoma, Large Cell
1
Adenocarcinoma
1
Interventions
Gemcitabine
6
Cisplatin
6
Capecitabine
6
Liver Transplantation
4
Fluorouracil
4
Specimen Handling
3
Radiosurgery
3
Oxaliplatin
3
Magnetic Resonance Spectroscopy
3
toripalimab
2
dehydroftorafur
2
Self Expandable Metallic Stents
2
Platinum
2
Leucovorin
2
Biopsy
2
1,2-diaminocyclohexaneplatinum II citrate
2
trisacryl gelatin microspheres
1
tremelimumab
1
trametinib
1
tislelizumab
1
temoporfin
1
sacituzumab govitecan
1
ricolinostat
1
pembrolizumab
1
lenvatinib
1
gemcitabine-oxaliplatin regimen
1
fludarabine
1
durvalumab
1
binimetinib
1
Tegafur
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Klatskin Tumor
×
temoporfin
×
Clear all
NCT03003065
2023-08-22
PDT
Chinese University of Hong Kong
Phase 2
Completed
10 enrolled